Howton David T

CIK 00015292973 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001529297

Recent Transactions

50 trades

Sale
Solid Biosciences Inc.$SLDB
Common Stock
2025-12-03$5.11/sh−4,932→ 32,908 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-12-02+13,051→ 37,840 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-12-02−13,051→ 13,052 total
Award
Solid Biosciences Inc.$SLDB
Employee Stock Option (Right to Buy)
2025-08-14+150,000→ 150,000 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-08-14+75,000→ 75,000 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2025-02-14$3.96/sh−5,561→ 24,789 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-02-13−14,687→ 44,063 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2025-02-13+14,687→ 30,350 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2025-01-31+169,100→ 169,100 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2024-12-03$5.60/sh−5,072→ 15,663 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-12-02−13,051→ 26,103 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2024-12-02+13,051→ 20,735 total
Award
Solid Biosciences Inc.$SLDB
Employee Stock Option (Right to Buy)
2024-02-13+117,500→ 117,500 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2024-02-13+58,750→ 58,750 total
Sale
Solid Biosciences Inc.$SLDB
Common Stock
2023-12-04$2.78/sh−5,367→ 7,684 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2023-12-02−13,051→ 39,154 total
Exercise/Conversion
Solid Biosciences Inc.$SLDB
Common Stock
2023-12-02+13,051→ 13,051 total
Award
Solid Biosciences Inc.$SLDB
Restricted Stock Units
2022-12-02+52,205→ 52,205 total
Award
Solid Biosciences Inc.$SLDB
Stock Option (Right to Buy)
2022-12-02+104,410→ 104,410 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-06-22−56,984→ 0 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$29.03/sh+45,000→ 136,993 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$13.71/sh+1,858→ 35,009 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-06-22−45,000→ 7,708 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-06-22−1,858→ 0 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$171.50/sh−55,270→ 31,871 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$168.61/sh−6,009→ 130,984 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$13.71/sh+1,280→ 33,151 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$23.85/sh+56,984→ 91,993 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-06-22−1,280→ 0 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$169.56/sh−8,086→ 122,898 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-06-22$170.59/sh−35,757→ 87,141 total
Award
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2020-02-28+6,700→ 31,871 total
Award
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2020-02-28+37,500→ 37,500 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−59,421→ 56,984 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$13.90/sh+18,579→ 43,750 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$125.50/sh−78,000→ 25,171 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-12-13$23.85/sh+59,421→ 103,171 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-12-13−18,579→ 0 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$105.00/sh−18,290→ 18,703 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$13.71/sh+4,025→ 28,413 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-11-22−8,580→ 18,579 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-11-22−7,900→ 5,118 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$13.90/sh+5,590→ 20,075 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$13.90/sh+8,580→ 36,993 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$13.71/sh+5,685→ 24,388 total
Sale
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$105.00/sh−3,753→ 14,950 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-11-22−2,440→ 2,470 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-11-22−4,025→ 1,858 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Stock option (right to buy)
2019-11-22−5,685→ 1,280 total
Exercise/Conversion
Sarepta Therapeutics, Inc.$SRPT
Common Stock
2019-11-22$23.85/sh+7,900→ 27,975 total

Companies

Recent Filings

Address

C/O VERTEX PHARMACEUTICALS INCORPORATED 130 WAVERLY ST

CAMBRIDGE, MA, 02139

View on SEC.gov